Ads
related to: moderna stock news update today live stream free no sign up
Search results
Results From The WOW.Com Content Network
A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). This update wasn't well-received by investors, and Moderna's share price sank nearly 17%. Moderna's stock chart certainly looks ...
*Stock Advisor returns as of January 21, 2025. Brett Schafer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Oracle. The Motley Fool recommends Moderna.
Wake up with Breakfast news in your inbox every market day. Sign Up For Free » Let's discuss the pros and cons of buying Moderna stock.
Over the past five trading sessions, the stock is up about 4%. In July 2024, Moderna was awarded $176 million from the US government to advance the development of its mRNA H5N1 (bird flu) vaccine ...
Moderna stock gained 14%, shooting up to $48.56 per share Tuesday afternoon. Vaccine-makers Novavax and CureVac similarly rose, soaring 15% and 10%, respectively, while Pfizer gained 2% and GSK ...
The company's stock was trading slightly up on the news early Monday before falling after market open. Moderna is up almost 20% in the last month after the company received approval from the FDA ...
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month.
Year to date, Moderna stock has plunged over 60%, with a 52-week low-high of $35.8-$170.47, as per data from Benzinga Pro. ... Moderna unveiled key updates at its annual R&D Day in September ...